[go: up one dir, main page]

WO2012175602A3 - Elisa for calprotectin - Google Patents

Elisa for calprotectin Download PDF

Info

Publication number
WO2012175602A3
WO2012175602A3 PCT/EP2012/061948 EP2012061948W WO2012175602A3 WO 2012175602 A3 WO2012175602 A3 WO 2012175602A3 EP 2012061948 W EP2012061948 W EP 2012061948W WO 2012175602 A3 WO2012175602 A3 WO 2012175602A3
Authority
WO
WIPO (PCT)
Prior art keywords
calprotectin
elisa
provides
quantification
monoclonal antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2012/061948
Other languages
French (fr)
Other versions
WO2012175602A2 (en
Inventor
Magne FAGERHOL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CALPRO AS
Original Assignee
CALPRO AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CALPRO AS filed Critical CALPRO AS
Publication of WO2012175602A2 publication Critical patent/WO2012175602A2/en
Publication of WO2012175602A3 publication Critical patent/WO2012175602A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

The present invention provides an improved method for the immunological detection and quantification of calprotectin, based on a monoclonal antibody. The invention further provides a method for selecting antibodies that react adequately with calprotectin in stool extracts.
PCT/EP2012/061948 2011-06-21 2012-06-21 Elisa for calprotectin Ceased WO2012175602A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20110896A NO336551B1 (en) 2011-06-21 2011-06-21 Improved ELISA for calprotectin in faecal or gastrointestinal tract test
NO20110896 2011-06-21

Publications (2)

Publication Number Publication Date
WO2012175602A2 WO2012175602A2 (en) 2012-12-27
WO2012175602A3 true WO2012175602A3 (en) 2013-06-13

Family

ID=46331308

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/061948 Ceased WO2012175602A2 (en) 2011-06-21 2012-06-21 Elisa for calprotectin

Country Status (2)

Country Link
NO (1) NO336551B1 (en)
WO (1) WO2012175602A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013132347A2 (en) * 2012-03-06 2013-09-12 Calpro As Improved elisa immunoassay for calprotectin
EP3248015B1 (en) * 2015-01-23 2025-05-14 Westfälische Wilhelms-Universität Münster Compounds and methods for the detection of calprotectin
CN108290058B (en) 2015-09-17 2023-05-16 美国安进公司 Predicting clinical response of IL23 antagonists using IL23 pathway biomarkers
JP2019508370A (en) 2015-12-22 2019-03-28 アムジェン インコーポレイテッド CCL20 as a Predictor of Clinical Response to IL23 Antagonists
EP3487874A1 (en) 2016-07-20 2019-05-29 Westfälische Wilhelms-Universität Münster Complex-specific standardization of immunological methods for the quantification of s100a12
CN110609143A (en) * 2019-10-31 2019-12-24 苏州普瑞森基因科技有限公司 Calprotectin heterodimer detection kit and application thereof
CN114891103B (en) * 2022-06-11 2023-07-07 巴迪泰(青岛)生物科技有限公司 Calprotectin monoclonal antibody and kit
CN117607461A (en) * 2023-12-06 2024-02-27 陕西省动物研究所 A detection method and application of S100A8 protein

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002088181A2 (en) * 2001-04-30 2002-11-07 Switch Biotech Ag Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0937259T3 (en) 1996-11-01 2005-01-31 Magne K Fagerhol Process for extracting proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002088181A2 (en) * 2001-04-30 2002-11-07 Switch Biotech Ag Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LUEGERING N ET AL: "Immunohistochemical distribution and serum levels of the Ca2+-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease", DIGESTION, S. KARGER AG., BASEL, CH, vol. 56, no. 5, 1 January 1995 (1995-01-01), pages 406 - 414, XP009019238, ISSN: 0012-2823, DOI: 10.1159/000201267 *
ROSETH A G ET AL: "ASSESSMENT OF THE NEUTROPHIL DOMINATING PROTEIN CALPROTECTIN IN FECES A METHODOLOGIC STUDY", SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, INFORMA HEALTHCARE, GB, vol. 27, no. 9, 1 January 1992 (1992-01-01), pages 793 - 798, XP009110340, ISSN: 0036-5521, DOI: 10.3109/00365529209011186 *

Also Published As

Publication number Publication date
NO20110896A1 (en) 2012-12-24
NO336551B1 (en) 2015-09-28
WO2012175602A2 (en) 2012-12-27

Similar Documents

Publication Publication Date Title
WO2012175602A3 (en) Elisa for calprotectin
WO2014165082A3 (en) Antibodies and methods of detection
MX337535B (en) Antibody, kit and method for determining amyloid peptides.
EP3638320A4 (en) Igf-1r monoclonal antibodies and uses thereof
NZ631098A (en) Anti-hepcidin antibodies and uses thereof
WO2014165771A3 (en) Anti-il-4 antibodies and bispecific antibodies and uses thereof
GB201108236D0 (en) Method
WO2011159537A3 (en) Method and device for analyte detection
WO2014144355A3 (en) Anti-gp73 monoclonal antibodies and methods of obtaining the same
EP3306310A4 (en) Method for quantifying monoclonal antibody
EP2550147B8 (en) Immunoassays, methods for carrying out immunoassays, immunoassay kits and method for manufacturing immunoassay kits
BR112013013573A2 (en) method for producing antibodies specific for an antigen of interest, isolated or recombinant b-cell, antibody population, and antibody
WO2013009521A3 (en) Methods and compositions for treating asthma using anti-il-13 antibodies
WO2014143343A8 (en) Hcv core lipid binding domain monoclonal antibodies
BR112012025082A2 (en) new monoclonal antibodies and d-dimer immunoassay method
MX349003B (en) Method for the detection of free binding partner of a multispecific binder.
WO2013049704A3 (en) Method and system of particle-phage epitope complex
MX349661B (en) Method for the detection of a binding partner of a multispecific binder.
WO2015006337A3 (en) Compositions and methods for increasing protein half-life in a serum
BR112012019475A8 (en) use of an anti-cd44 monoclonal antibody, anti-cd44 monoclonal antibody, humanized anti-cd44 antibody and kit for detecting hnscc in a sample
WO2013115410A3 (en) Anti-phospholipase d4 antibody
HK1220207A1 (en) Humanized anti-n2 antibodies
EP3375875A4 (en) SEPARATING AGENT FOR HUMAN SERUM-DERIVED IgG POLYCLONAL ANTIBODIES, AND METHOD FOR SEPARATING HUMAN SERUM-DERIVED IgG POLYCLONAL ANTIBODIES USING SAME
EP3722311A4 (en) Anti-human il6 monoclonal antibodies, preparation method therefor and use thereof
GB201119585D0 (en) Assay

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12729114

Country of ref document: EP

Kind code of ref document: A2

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC

122 Ep: pct application non-entry in european phase

Ref document number: 12729114

Country of ref document: EP

Kind code of ref document: A2